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Objectives: Diabetic patients respond poorly to revascularization for peripheral arterial
disease (PAD) but the underlying mechanisms are not well understood. We aimed
to determine whether diabetes worsens ischemia-reperfusion (IR)-induced muscle
dysfunction and the involvement of endogenous protective kinases in this process.
Materials and Methods: Streptozotocin-induced diabetic and non-diabetic rats were
randomized to control or to IR injury (3 h of aortic cross-clamping and 2 h of reperfusion).
Mitochondrial respiration, reactive oxygen species (ROS) production, protein levels of
superoxide dismutase (SOD2) and endogenous protective kinases (RISK and SAFE
pathways) were investigated in rat gastrocnemius, together with upstream (GSK-3β) and
downstream (cleaved caspase-3) effectors of apoptosis.
Results: Although already impaired when compared to non-diabetic controls at
baseline, the decline in mitochondrial respiration after IR was more severe in diabetic rats.
In diabetic animals, IR-triggered oxidative stress (increased ROS production and reduced
SOD2 levels) and effectors of apoptosis (reduced GSK-3β inactivation and higher cleaved
caspase-3 levels) were increased to a higher level than in the non-diabetics. IR had no
effect on the RISK pathway in non-diabetics and diabetic rats, but increased STAT 3 only
in the latter.
Conclusion: Type 1 diabetes worsens IR-induced skeletal muscle injury, endogenous
protective pathways not being efficiently stimulated.
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INTRODUCTION
Diabetes is a major risk factor for peripheral arterial disease
(PAD) and in patients with diabetes, PAD is more severe
and has a poorer response to revascularization (Jude et al.,
2001; DeRubertis et al., 2008; Malmstedt et al., 2008). Yet, the
mechanisms linking diabetes to worse outcomes in PAD are
not well understood. Diabetes per se impairs skeletal muscle
mitochondrial function (Kelley et al., 2002; Bonnard et al.,
2008; Anderson et al., 2009). In type 1 diabetic patients
the skeletal muscles present reduced mitochondrial oxidative
phosphorylation, even without obvious vascular abnormalities
(Karakelides et al., 2007) and the mitochondrial impairment may
even precede hyperglycemia in type 2 diabetes (Petersen et al.,
2004). These data suggest that mitochondrial dysfunction may be
a common pathway of diabetes and PAD severity.
When PAD ischemia becomes critical, blood flow has to be
reestablished by revascularization. However, the return in blood
flow causes additional muscle damage. This paradoxical and
detrimental effect is known as ischemia-reperfusion injury (IRI).
Although the cause of PAD is occlusive arterial disease, muscle
mitochondrial dysfunction is also critical for the severity of PAD.
These abnormalities include impaired mitochondrial respiration
and increased oxidative stress, and are present in both chronic
PAD and after ischemia-reperfusion (IR) (Pipinos et al., 2006;
Makris et al., 2007; Tran et al., 2012; Guillot et al., 2014; Lejay
et al., 2014, 2017; Paradis et al., 2016). While it is generally
assumed that muscle mitochondria are more susceptible to IRI in
diabetic subjects, data supporting this assertion are lacking. Very
little is known regarding the magnitude of the mitochondrial
dysfunction and the mechanisms involved in this process.
It is well established that myocardial IR induces the
reperfusion injury salvage kinase (RISK) and survivor activating
factor enhancement (SAFE) protective pathways (Lecour, 2009;
Rossello and Yellon, 2017). Decreased myocardial activation
of RISK and SAFE increases the susceptibility of the diabetic
heart to IRI (Tsang et al., 2005; Drenger et al., 2011). Acute
activation of RISK and SAFE effectors appear to converge
on the mitochondria and avert cell damage. In brief, RISK
signaling involves protein kinase B (Akt) phosphorylation
which, in turn, phosphorylates and inactivates glycogen
synthase kinase 3β (GSK-3β). Inactivated GSK-3β cannot induce
mitochondrial permeability transition pore (mPTP) opening
anymore, thus preventing mitochondrial dysfunction and
apoptosis (Juhaszova et al., 2004). SAFE activation involves
phosphorylation and hence, activation of signal transducer
and activator of transcription 3 (STAT3). Activated STAT3
stimulates mitochondrial respiration, inhibits mPTP opening
Abbreviations: Akt, protein kinase B; DHE, dihydroethidium; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; GSK-3β, glycogen synthase kinase 3β;
IR, ischemia-reperfusion; IRI, ischemia-reperfusion injury; mPTP, mitochondrial
permeability transition pore; PAD, peripheral arterial disease; RISK, reperfusion
injury salvage kinases; ROS, reactive oxygen species; SAFE, survivor activating
factor enhancement; SOD2, mitochondrial manganese superoxide dismutase;
STAT3, signal transducer and activator of transcription 3; TMPD, N, N, N’,
N’-tetramethyl-p-phenylenediamine dihydrochloride.
and attenuates apoptosis. Yet, the involvement of these pathways
in skeletal muscle IR is unknown.
The purpose of this study was to investigate the impact of type
1 diabetes on the skeletal muscle IRI and examine the activation
of the RISK and SAFE pathways. We assessed mitochondrial
respiration, oxidative stress, and effectors of apoptosis and of
RISK and SAFE pathways, in streptozotocin-treated, type 1
diabetic rats, in comparison to non-diabetic controls.
MATERIALS AND METHODS
Experimental Animals
Experiments were performed on 8-week-old male Wistar
rats (Depré, Saint-Doulchard, France), either vehicle-treated
or streptozotocin-treated to induce insulin-dependent type 1
diabetes. The study conformed to the “Principles of laboratory
animal care” (NIH publication 85–23, revised 1985) and
was approved by the Institutional Animal Care Committee
(CREMEAS AL/02/10/06/2009).
Induction of Diabetes
Type 1 diabetes was induced in male rats by a single 65
mg/kg streptozotocin injection in the penile vein. Animals were
considered diabetic when blood glucose was above 16.7 mmol/L,
8 days after induction of diabetes. Non-diabetic vehicle-treated
animals received intravenous saline injection at the same time.
Six weeks after diabetes induction, streptozotocin-treated and
vehicle-treated rats were individually housed in metabolic cages
for 2 days. After the first day (considered an acclimation period),
blood glucose concentrations, food and water intake and urine
output were recorded over a 24-h period.
Thirty days after diabetes induction, an oral glucose-tolerance
test was performed in diabetic rats and non-diabetic animals to
confirm the diabetic status of the formers. The test consisted
in a 2 g/kg glucose loading given by oral gavage after a 12-h
fasting period. Glucose concentrations were determined on tail
vein blood at 20, 40, 60, 120, and 180min after gavage.
Animal Surgical Preparation and Procedure
As previously described (Mansour et al., 2012), after performing
a midline laparotomy under isoflurane anesthesia, the infra-
renal abdominal aorta was dissected and freed from adjacent
adhesions. All arterial collaterals located between the renal
arteries and the aortic bifurcation, were coagulated and sectioned
using electrocautery (Geiger R©, thermal cautery unit).
Experimental Design
Seven weeks after vehicle or streptozotocin injection, rats
(referred to as non-diabetic “n,” and diabetic “d,” respectively)
were randomly assigned to the control (CON) or IR group. The
control groups (nCON, dCON, 8 rats per group) underwent
5 h of isoflurane anesthesia and similar surgical manipulation to
the IR groups, except for hindlimb ischemia (sham-operated).
The ischemia–reperfusion groups (nIR and dIR, 10 rats per
group) underwent 3 h of ischemia induced by infra-renal aortic
occlusion and collateral vessel ligation, followed by 2 h of
reperfusion. Ischemia was clinically characterized by cyanosis
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and lack of an arterial pulse distal to the clamp, and biochemically
by an increase in capillary blood lactate measured in the right
hindlimb (Lactate Pro device, LT1710; Arkray, KGK, Japan).
After reperfusion, gastrocnemius muscles, that are considered
more sensitive to IR (Charles et al., 2017), were harvested
and either analyzed immediately (mitochondrial respiration) or
kept in ice or in liquid nitrogen-cooled isopentane. Animals
were sacrificed by heart retrieval under deep anesthesia (5%
isoflurane).
Study of Muscle Mitochondrial Respiration
in Skinned Fibers
Mitochondrial respiration was studied in saponin-skinned
fibers of white gastrocnemius muscle (glycolytic muscle), as
previously described (Talha et al., 2013). Fibers were separated
and subsequently permeabilized in a bath of solution S
containing 50µg/ml saponin for 30min at 4◦C, under shaking.
Permeabilized fibers were washed for 10min under shaking, to
remove the saponin, and placed in a bath with the respiratory
solution for 5min twice, in order to remove any phosphates.
Finally, oxygen consumption was measured polarographically
with a Clark-type electrode in a 3ml oxygraphic cell (Strathkelvin
Instruments, Glasgow, Scotland) at 22.1◦C in incubation buffer
using 5mM glutamate and 2.5mM malate as substrates for
complex I, or 25mM succinate (in combination with 0.02mM
amytal to inhibit complex I) as substrate for complex II.
After recording of basal oxygen consumption (V0), maximal
fiber respiration (VMax) rate was measured under continuous
stirring in the presence of a saturating amount of ADP
(2mM) as a phosphate acceptor. Relative contributions of
the respiratory chain complexes I, III and IV to the global
mitochondrial respiratory rates were also determined. When
VMax was recorded, the electron flow went through complexes
I, III, and IV. For determining VSucc, complex I was
blocked with amytal (0.02mM) and complex II was stimulated
with succinate (25mM). Mitochondrial respiration in these
conditions allowed to determine the contribution of complexes
II, III, IV activities. Thereafter, N, N, N′, N′-tetramethyl-
p-phenylenediamine dihydrochloride (TMPD, 0.5mM) and
ascorbate (0.5mM) were added as an artificial electron donor
to cytochrome c. In these conditions, the activity of cytochrome
c oxidase (complex IV) was determined as an isolated step
of the respiratory chain (VTMPD). In all cases, mitochondrial
respiration assays in skinned fibers were performed immediately
after harvesting. Fibers were then dried for 15min at 150◦C and
respiration rates were expressed as µMO2/min/g dry weight.
Assessment of Oxidative Stress in Skeletal
Muscles
Assessment of Reactive Oxygen Species Production
in Skeletal Muscle by Dihydroethidium Staining
As described previously (Pottecher et al., 2013), 10 µm-thick
serial sections of white gastrocnemius muscle were prepared
using a cryostat microtome and incubated with dihydroethidium
(DHE) that produces red fluorescence when oxidized to ethidium
bromide (EtBr) by ROS, including superoxide anion (Li and
Jackson, 2002; Sheetz and King, 2002; Charles et al., 2011). To
assess ROS production in each skeletal muscle section, mean
fluorescence intensity (arbitrary units) was determined in 25
regions of interest under 20× epifluorescence magnification.
As ROS production by diabetic skeletal muscle mitochondria
may be confounded by concurrent changes in respiration rates,
this may leave raw, unadjusted ROS levels unchanged, while
specific ROS production may increase, when considered relative
to electron transport (Herlein et al., 2011). Consequently, the
mean DHE fluorescence was divided by the mitochondrial
respiration rate from skinned fibers.
Protein Levels of the Antioxidant Mitochondrial
Manganese Superoxide Dismutase in Skeletal
Muscles by Western Blot
This assessment is detailed below in the following paragraph.
Protein Extraction and Analysis
Gastrocnemius muscles were grounded in a mortar at 4◦C
in RIPA buffer [50mM Tris pH 7.5, 1% Nonident P40, 0.5%
sodium deoxycholate, 0.1% SDS, 150mM NaCl, 5mM EDTA,
1mM PMSF and phosphatase and protease inhibitor cocktails
according to the manufacturer’s protocol (PhosphoStop
and Complete-Mini EDTA free, Roche)]. Homogenates (50
µg of protein, n = 3–6 per group) were electrophoresed
on polyacrylamide gels. Proteins were electroblotted onto
nitrocellulose membranes using a Trans-blot turbo transfer
system (Biorad) and immunodetected using primary antibodies
directed against SOD2 (SOD-110, StressGen), Akt (4691,
Cell Signaling), phospho-Akt Ser473 (4060, Cell Signaling),
phospho-Akt Thr308 (4056, Cell Signaling), GSK-3β (610201,
BD Biosciences), phospho-GSK-3β Ser9 (5558, Cell Signaling),
STAT3 (9132, Cell Signaling), phospho-STAT3 Tyr705 (9131,
Cell Signaling), cleaved caspase-3 (9661, Cell Signaling),
tubulin and GAPDH (MAB374, Millipore Upstate Chemicon),
according the manufacturer’s instructions. Proteins were
revealed with secondary antibodies conjugated to horseradish
peroxidase (Amersham Biosciences) using an enhanced
chemiluminescence detection system (ECLplus, GE Healthcare)
and an ImageQuant
TM
LAS 4000 biomolecular imager (GE
Healthcare). Immunodetected proteins were quantified with the
FIJI software and normalized to GAPDH levels (except cleaved
caspase-3, which was normalized to tubulin levels).
Statistics
All data are expressed as mean ± standard error of the mean
(SEM), and were analyzed using Prism software (GraphPad
Prism 5, Graph Pad Software, San Diego, USA). Comparisons
between two groups were performed by Student two-tailed t-test.
Two-way analysis of variance (ANOVA) was applied to test
simultaneously the main effects and interaction for diabetes
status and ischemia. Comparisons between more than two
groups were performed using one-way ANOVA with Newman-
Keuls post-hoc correction for multiple comparisons. Repeated-
measures ANOVA was conducted when appropriate. In all cases,
a p-value < 0.05 was considered statistically significant.
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RESULTS
Hemodynamic and Metabolic Changes in
Diabetic and Non-diabetic Animals
Compared to vehicle-treated animals, streptozotocin-treated rats
displayed typical features of type 1 diabetes with hyperglycemia,
polyuria, polydipsia, polyphagia and decreased body weight.
Baseline heart rate was similar in both groups although
streptozotocin-treated rats exhibited mild arterial hypertension
(164 ± 5, mmHg vs. 140 ± 3; p < 0.001). The absolute
and relative maximal increases in blood glucose were higher
in streptozotocin-treated than in the non-diabetic rats (+319
± 9 mg/dL vs. +73 ± 4 mg/dL and 309 ± 24% vs. 200 ±
4%, respectively; p < 0.001) (Figure 1). Hind limb capillary
blood lactate levels pre-IR were similar between streptozotocin-
and vehicle-treated animals (2.8 ± 0.3 and 2.6 ± 0.4 mmol/L
respectively, p = NS), and were similarly increased at the end of
the 3 h ischemia (17.7 ± 0.5 vs. 18.9 ± 0.9 mmol/L respectively,
p= NS).
Heart rate changes were also not statistically different between
diabetic and non- diabetic animals at baseline, at the end of
ischemia and after 2 h of reperfusion (data not shown). These
results suggest that streptozotocin- and vehicle-treated animals
were subjected to a similar ischemic insult.
Mitochondrial Respiratory Chain Complex
Activities Are More Impaired After IR in
Diabetic Animals Than in Controls
Among controls, oxygen consumption was halved in
streptozotocin-treated rats as compared to non-diabetic
rats (Figure 2A). Ischemia-reperfusion decreased VMax in
both diabetic and non-diabetic animals (Figure 2A). However,
VMax was significantly more reduced after IR in type 1 diabetic
rats compared to the non-diabetics (−57 ± 14% vs. −23 ± 7%;
p< 0.05, Figure 2B). While IR did not alter VSucc in non-diabetic
animals (−11 ± 6%; p = NS), it induced a significant decrease
FIGURE 1 | Time course of blood glucose in streptozotocin-treated (diabetic)
and non-diabetic rats during an oral glucose tolerance test. ***p < 0.001.
in VSucc in diabetic rats (−60 ± 7%; p < 0.001 compared
to non-diabetic animals). IR did neither alter VTMPD/Asc in
streptozotocin- nor in non-diabetic animals (Figure 2B). These
results show that, after IR, mitochondrial respiration is more
impaired in diabetic than in non-diabetic animals.
Larger Increase in Oxidative Stress in
Diabetic Animals
After IR, we observed a 2-fold increase in raw DHE fluorescence
in vehicle-treated rats (p < 0.001). In contrast, DHE staining,
FIGURE 2 | Mitochondrial respiration in gastrocnemius muscles from
vehicle-treated and streptozotocin-treated rats with and without hindlimb
ischemia-reperfusion. (A) Mitochondrial respiration was determined in
gastrocnemius muscles from sham-operated, vehicle-treated (nCON) or
streptozotocin-treated rats (dCON), and after ischemia reperfusion in
vehicle-treated (nIR) and streptozotocin-treated rats (dIR). Maximal fiber
respiration (VMax) rate, combined complexes II, III, IV activities (VSucc) and
isolated complex IV activity (VTMPD) were measured. Results are expressed
as mean ± SEM [µM O2/min/g dry weight tissue]. *p < 0.05; **p < 0.01; ***p
< 0.001, ap < 0.05 for diabetes effect; bp < 0.05 for IR effect; #p < 0.05 for
interaction. (B) Variations in mitochondrial respiration in gastrocnemius
muscles obtained after ischemia-reperfusion vs. sham operation in
vehicle-treated (“nIR”) and streptozotocin- treated rats (“dIR”). Results show a
variation in oxygen consumption after ischemia- reperfusion vs. sham
operation, expressed as percent decrease ± SEM. § indicates that the variation
is significantly different from zero, while *p < 0.05 and ***p < 0.001 indicate
that the variation is significantly different between diabetic and non-diabetic
rats.
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which was already enhanced in the diabetic rats, was not
further increased after IR in this group (Figures 3A,B). However,
ROS levels normalized either to VMax (DHE/VMax) or VSucc
(DHE/VSucc) were significantly increased after IR in both diabetic
and non-diabetic rats, but to a larger extent in diabetic animals
(Figure 3B).
The antioxidant SOD2 level was conversely 3-fold lower
in diabetic rats after IR (Figure 3C). Thus, diabetic muscles
produced more ROS and had reduced antioxidant defenses
after IR.
Safe and Risk Pathways Implications in
Diabetic Rats After IR
To test whether the alterations on mitochondrial function and
oxidative stress after IR were associated with activation of
the endogenous protective kinases, we investigated the effector
proteins of RISK (Akt) and SAFE (STAT3) pathways.
Among controls (no IR), the activated Akt (phosphorylated
at the threonine 308 and the serine 473 residues) was higher in
the non-diabetic rats (p < 0.01). After IR, the phosphorylated
Akt levels did neither change in diabetic, nor in non-diabetic rats,
indicating no RISK activation. However, both diabetic groups had
consistently lower levels of activated Akt than their non-diabetic
counterparts (p < 0.01; Figures 4A,B).
Regarding SAFE pathway, the active, phosphorylated form
of STAT3 was not different between diabetic and non-diabetic
rats who did not undergo IR. After IR, the phosphorylated
STAT3 levels showed a significant 2-fold increase in the diabetic
animals only (p < 0.01) (Figure 4C). Therefore, one effector of
the SAFE pathway is activated by IR in diabetic but not in in the
non-diabetic rats.
Decreased GSK-3β Inhibition and
Increased Cleaved caspase-3 and Cell
Damage in Diabetic Rats After IR
While the phosphorylated GSK-3β levels were not altered after
IR in non-diabetic animals, they dropped markedly in diabetic
rats (p < 0.01), resulting in a 2.5-fold decrease in phospho-
GSK-3β/GSK-3β ratio (Figure 5A). Thus, after IR, the protective,
phosphorylated GSK-3β was markedly lower in the diabetic than
in the non-diabetic animals and was even lower compared to the
diabetic rats that did not undergo IR (p < 0.05 and p < 0.01
respectively). Cleaved caspase-3 is a strong downstream effector
of mitochondrial-mediated apoptosis and characterized as the
“key executioner” of apoptosis.
IR was followed by an increased cleaved caspase-3 expression
in gastrocnemius, which was non-significant in non-diabetic
animals and highly significant in diabetic rats. Moreover, the
increased expression of cleaved caspase 3 was 6-fold larger in
the muscles of diabetic animals than in the muscles of their
non-diabetic counterparts (p < 0.0001) (Figure 5B).
Taken together, the decreased levels of inactivated GSK-3β and
the increased levels of cleaved caspase-3 in the diabetic animals
after IR, denote a reduced protection against IRI and a strong
trend for apoptosis (presumably through mPTP opening) and
cell damage. RepresentativeWestern blots of the effector proteins
FIGURE 3 | Reactive oxygen species production and antioxidant protein level.
(A) Representative histological sections after dihydroethidium (DHE) staining in
sham- operated, vehicle-treated (nCON) or streptozotocin-treated rats
(dCON), and after ischemia reperfusion in vehicle-treated (nIR) and
streptozotocin-treated rats (dIR). (B) Raw and specific (normalized to
respiration rate) reactive oxygen species (ROS) production in gastrocnemius
muscles from sham-operated, vehicle-treated (nCON) or
streptozotocin-treated rats (dCON), and after ischemia reperfusion in
vehicle-treated (nIR) and streptozotocin-treated rats (dIR). Data are expressed
as mean ± SEM [Arbitrary Unit/µM O2/min/g dry weight]. *p < 0.05; **p <
0.01; ***p < 0.001, ap < 0.05 for diabetes effect; bp < 0.05 for IR effect.
(C) Quantification of mitochondrial superoxide dismutase (SOD2) protein level
by Western blotting in gastrocnemius muscles from sham-operated,
vehicle-treated (nCON) or streptozotocin-treated rats (dCON), and after
ischemia reperfusion in vehicle-treated (nIR) and streptozotocin-treated rats
(dIR). Data are expressed as the mean ± SEM of the intensity of the SOD2
bands reported to the intensity of the internal control
(glyceraldehyde-3-phosphate dehydrogenase, GAPDH). *p < 0.05; **p <
0.01, ap < 0.05 for diabetes effect; bp < 0.05 for IR effect; #p < 0.05 for
interaction.
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FIGURE 4 | Protein levels of key components of the endogenous protective
RISK and SAFE pathways. Quantification of the levels of effector proteins from
the RISK pathway [Akt, phospho-Akt/Total Akt Thr308 (A), phospho-Akt/Total
Akt Ser473 (B)] and the SAFE pathway [STAT3, phospho-STAT3/Total STAT3
tyr705 (C)] in gastrocnemius muscle from sham-operated, vehicle-treated
(nCON) or streptozotocin-treated rats (dCON), and after ischemia reperfusion
in vehicle-treated (nIR) and streptozotocin-treated rats (dIR). GAPDH was used
as an internal control for all proteins. Data are expressed as the mean ± SEM
of the intensity of the bands reported to the intensity of the internal control.
*p < 0.05; **p < 0.01, ap < 0.05 for diabetes effect; #p < 0.05 for interaction.
FIGURE 5 | Protein levels of GSK-3β and cleaved caspase-3. Quantification of
the levels of (A) GSK-3β, (GSK-3β, phospho-GSK-3β/Total GSK-3β Ser9) and
(B) caspase-3 effector of apoptosis in gastrocnemius muscle from
sham-operated, vehicle-treated (nCON) or streptozotocin-treated rats (dCON),
and after ischemia reperfusion in vehicle-treated (nIR) and
streptozotocin-treated rats (dIR). GAPDH was used as an internal control
except cleaved caspase-3 for which tubulin was used. Data are expressed as
the mean ± SEM of the intensity of the bands reported to the intensity of the
internal control. *p < 0.05, **p < 0.001, ****p < 0.0001, ap < 0.05 for
diabetes effect; bp < 0.05 for IR effect; #p < 0.05 for interaction.
(RISK and SAFE pathways, together with cleaved caspase 3) are
provided in Figure 6.
Histological gastrocnemius samples from the diabetic-IR
rats invariably showed totally distorted anatomy with extensive
necrosis and cell lysis, compared to the non-diabetic-IR animals
that presented much less severe cell injury (Figure 7).
DISCUSSION
The main finding of this study is that the impact of skeletal
muscle IRI is worse in subjects with type 1 diabetes phenotype.
Before ischemia, mitochondrial respiration and oxidative stress
were more impaired in animals with diabetes than in those
without, and these differences became more prominent after IR.
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FIGURE 6 | Representative Western blots of the effector proteins. (Upper
panel) Effector proteins of RISK and SAFE pathways. (Lower panel) Cleaved
caspase-3. GAPDH was used as an internal control except cleaved caspase-3
for which tubulin was used.
Despite activation of one effector of the SAFE pathway, apoptosis
and cell damage also appear to be more severe in diabetic subjects
after IR. To the best of our knowledge, this is the first study
that examined the combined effect of IR and diabetes on skeletal
muscle.
Impaired skeletal muscle mitochondrial function and
increased oxidative stress are the key elements of PAD-related
IR injury (Tran et al., 2011; Guillot et al., 2014). Increased
ROS production appears to precede (Guillot et al., 2014) and
mediate mitochondrial dysfunction in skeletal muscles. In
turn, dysfunctional mitochondria increase ROS production in a
vicious cycle (Zorov et al., 2006; Chouchani et al., 2014). Type
1 and type 2 diabetes are also independently associated with
increased oxidative stress and defective mitochondrial function,
in both humans and experimental models (Kelley et al., 2002;
Petersen et al., 2004; Karakelides et al., 2007; Bonnard et al., 2008;
Anderson et al., 2009). Put in context, our results indicate that,
after IR, diabetes further compromises mitochondrial function
and oxidative stress in skeletal muscles, and suggest a cumulative
or synergistic deleterious effect of both pathologies. A plausible
mechanistic explanation could be that the diabetes-induced
compromised mitochondrial function may be predisposing the
limb muscles to respond poorly to IRI.
In the same line of evidence, Ryan et al., investigating the
impact of type 2 diabetes on mice with acute limb ischemia,
also reported exacerbation of skeletal musclemitochondriopathy,
oxidative stress and necrosis in diabetic animals. Although they
did not extend their observations to the reperfusion period,
they reported a reversal of these disturbances, by overexpression
of catalase-mediated antioxidant defenses (Ryan et al., 2016).
Bonnard et al. observed mitochondrial alterations that were
similar in both type-1 and type-2 diabetic mice and associated
with ROS production. Interestingly, the authors found that
normalization of glycemia (by insulin) or antioxidant treatment
restored mitochondrial integrity and reversed the proapoptotic
process in the type-1 diabetic animals (Bonnard et al., 2008).
Other studies, focusing on diabetic myocardium, have also shown
that diabetes was associated with increased susceptibility to IRI
(Whittington et al., 2012). Most of these studies suggested that
the hyperglycemia-induced elevated levels of ROS and depletion
of antioxidants were the key players in diabetic IRI (Ceriello et al.,
2000; Nishikawa et al., 2000; Song et al., 2007).
Although present in skeletal muscles (Sandri, 2008), RISK
and SAFE pathways activation has not been previously examined
before in skeletal muscle IR. In this study, reduced Akt activation
in diabetic animals indicates that the RISK pathway is not
activated, and is consistent with the low inhibition of GSK-3β.
GSK-3β is the downstream point of convergence of the RISK
pathway and of several other prosurvival pathways and when
phosphorylated (and thus inhibited) prevents mPTP opening
(Juhaszova et al., 2004). Therefore, the lower levels of inactive
GSK-3β in diabetic rats after IR may suggest failure of RISK
and other protective pathways, ultimately resulting in mPTP
opening, apoptosis and cell death. Consistently, downstream
to GSK-3β, the proapoptotic cleaved caspase-3 levels were
several times higher in diabetic rats. Several cardiac studies in
diabetes also reported that hyperglycemia, insulin deficiency and
insulin resistance were associated with loss of the conditioning-
mediated cardioprotection and that this effect was driven by
impaired signaling to Akt and GSK3β of the RISK pathway
(Tsang et al., 2005; Gross et al., 2007; Song et al., 2007). In
cardiomyocytes, upon IR, Akt activation appeared to be maximal
after 10min, remained elevated until 60min of reperfusion, and
returned toward basal levels by 2 h (Mockridge et al., 2000).
Notwithstanding the lack of RISK activation at 2 h of reperfusion
in our experiment, activation of RISK at an earlier timepoint
cannot be excluded.
In contrast to RISK, SAFE pathway appeared to be activated
in our diabetic animals after IR, as we observed an increased
activation of STAT3. As a part of the SAFE pathway, STAT3 is
involved in ischemic conditioning. Through its localization in the
mitochondria of several organs, STAT3 modulates mitochondrial
respiration and attenuates ROS production, mPTP opening and
apoptosis (Wegrzyn et al., 2009). SAFE activation in diabetic
animals should have been protective and yet, we found much
higher cleaved caspase-3 levels in this group. These seemingly
contradictory results may have several explanations. SAFE and
RISK activation protects ischemic myocardium when triggered
acutely, at the very first minutes of reperfusion, by specific
conditioningmaneuvers or pharmacological agents (Rossello and
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FIGURE 7 | Hematoxylin-eosin staining of gastrocnemius muscles from sham-operated, vehicle-treated (nCON) and streptozotocin-treated rats (dCON), and after
ischemia reperfusion in vehicle-treated (nIR) and streptozotocin-treated rats (dIR). Magnification ×400. Compared to nCON, gastrocnemius muscles from dCON rats
showed reduced muscle fiber diameter, increased number of inflammatory cells invading the intercellular space (thin black, swept arrowheads) and intercellular edema
(large black, solid arrowheads). After IR, gastrocnemius muscles from the nIR group displayed both increased intercellular and intracellular edema (large gray, solid
arrowheads). After IR, gastrocnemius from the dIR group showed totally distorted anatomy with extensive necrosis and cell lysis surrounded by clusters of
inflammatory cells (thin black, swept arrowheads).
Yellon, 2017). In our study, STAT3 activation was spontaneous
and hence, may not be sufficient or not activated early enough,
to completely counteract the brunt of the increased oxidative
stress. While spontaneous STAT3 activation has been shown to
occur after myocardial ischemia and was further increased by
reperfusion, it failed to reduce the infarct size (Hausenloy et al.,
2011). Interestingly, STAT3 activation, despite its acute protective
myocardial effects after IR, has also been strongly implied in
atrophying skeletal muscle in experimental models of cancer
cachexia or renal failure (Piccirillo and Giavazzi, 2015). Contrary
to many chronic conditions, STAT3 activation usually triggers
protective mechanisms in acute situations (like IR), probably
accounting for the widespread “SAFE” label. In some situations,
like in our study, one should probably not use the “SAFE”
acronym, because STAT3 is not protective.
In our study, activated cleaved caspase-3 was several times
higher in diabetic than in the non-diabetic subjects after IR,
suggesting a strong trend toward apoptosis and cell death. Our
histological findings, although not formally quantified, strongly
corroborated this assertion. Chowdhry et al. reported comparable
results in diabetic human myocardium. They demonstrated that
diabetes increased both necrosis and apoptosis after IR, and
that this effect was mediated by caspase-3 (Chowdhry et al.,
2007). Other studies have also shown that increased activation
of caspase-3 increased myocardial infarct size and that inhibiting
caspases at the time of reperfusion, limited the infarct size
(Mocanu et al., 2000; Condorelli et al., 2001). In skeletal muscles,
caspases also mediate apoptosis after IR and trigger accelerated
proteolysis in catabolic conditions (Du et al., 2004; Tran et al.,
2012).
Several limitations of this study need to be acknowledged.
Although the general limitations of the preclinical models
may also apply to our study, we used a well-characterized
pharmacological model of type 1 diabetes. Our data are
descriptive and do not test specific mechanisms. That these
pathways andmitochondrial function are altered in specific ways,
simply make a series of observations and causality cannot be
established. RISK and SAFE in skeletal muscle are investigated for
the first time in this IR study and the analyses were performed at
a single timepoint, after 3 h of ischemia and 2 h of reperfusion. In
this regard, further studies are needed to determine the kinetics
and the mechanisms of the different effectors. Executioner
caspase-3 alone, although strongly inferring apoptosis and cell
damage, cannot formally be interpreted as evidence of ultimate
cell death. However, the histological findings seem to confirm a
more extensive cell damage in the diabetic group.
In conclusion, our experimental data demonstrate that
mitochondrial dysfunction, oxidative stress and apoptosis are
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enhanced in type 1 diabetes, after lower-limb IR. The so-called
RISK and SAFE protective pathways appeared not to be activated
in diabetic animals after IR, despite STAT 3 enhancement,
potentially explaining the increased susceptibility to apoptosis
and cell damage. These disturbances may contribute toward
the high failure rate of revascularization in diabetic subjects
with PAD. More studies are needed to further elucidate the
mechanisms of IR mitochondriopathy in diabetes, determine the
impact of specific anti-diabetic treatments on mitochondrial IR
dysfunction and clarify the kinetics and the role of the protective
pathways. Therapeutic approaches targeting mitochondria may
reduce lower-limb IR damage and improve local and general
prognosis in patients with PAD.
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